ACTA ENDOCRINOLOGICA (BUC)

Pseudoobstruction is an uncommon manifestation of hypothyroidism. However,\r\nhypotony of the bladder in myxedema is very rare, and there were only four such cases\r\nreported previously. We present a 45-year-old man with myxedema and ileus, who was\r\nstarted on thyroxine therapy and was detected to have bladder hypotony on the 5th day of\r\nadmission. There was no evidence of bladder outflow obstruction, and both bowel and\r\nurinary symptoms improved with thyroxine therapy. Bladder hypotony may be more\r\nprevalent in patients of hypothyroidism than previously reported; hence, it is important to\r\nhave a high clinical suspicion and perform early urodynamic studies to avoid back-pressure\r\ndamage to the upper tracts.

Carbimazole is a common drug used to treat hyperthyroidism. Agranulocytosis is a known adverse effect of these anti-thyroid drugs but plasmacytosis simulating multiple myeloma is a very uncommon manifestation of this drug. We report here the case of a patient of hyperthyroidism who developed febrile neutropenia while on carbimazole with the preliminary marrow findings simulating plasma cell myeloma.